GS
CURE icon

GTS Securities’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

GTS Securities’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,929
Closed -$1.09M – 1440
2026
Q1 		$1.09M Sell
11,929
-12,105
-50% -$1.31M 0.04% 361
2025
Q4 		$2.68M Sell
24,034
-8,447
-26% -$864K 0.09% 168
2025
Q3 		$2.72M Buy
32,481
+26,008
+402% +$2.03M 0.1% 159
2025
Q2 		$510K Sell
6,473
-23,279
-78% -$1.88M 0.02% 652
2025
Q1 		$3.17M Buy
29,752
+15,542
+109% +$1.65M 0.14% 108
2024
Q4 		$1.31M Buy
+14,210
New +$1.6M 0.06% 249
2024
Q3 		– Sell
-48,959
Closed -$5.73M – 4116
2024
Q2 		$5.73M Buy
48,959
+15,260
+45% +$1.72M 0.01% 780
2024
Q1 		$4.23M Sell
33,699
-7,572
-18% -$881K 0.01% 978
2023
Q4 		$4.19M Buy
41,271
+19,535
+90% +$1.75M 0.01% 1128
2023
Q3 		$1.92M Sell
21,736
-1,239
-5% -$122K ﹤0.01% 1538
2023
Q2 		$2.3M Buy
+22,975
New +$2.29M 0.07% 244

Other funds holding CURE

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

GTS Securities's CURE Position: Q2 2026 in Review

GTS Securities sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2026, closing a stake of 11,929 shares — an estimated $1.09M sold.

GTS Securities first reported a position in CURE in Q2 2023 and held it in 11 quarters. The position peaked at $5.73M in Q2 2024. 19 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

  • GTS Securities reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 11,929 Direxion Daily Healthcare Bull 3X ETF shares in Q2 2026, an estimated $1.09M.
  • GTS Securities first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2023 and held it in 11 quarters.
  • GTS Securities's Direxion Daily Healthcare Bull 3X ETF position peaked at $5.73M in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.